Oropharyngeal dysphagia in infants and children with infantile Pompe disease

Dysphagia

Volumn 25, Issue 4, 2010, Pages 277-283

  Jones, Harrison N ^a   Muller, Carolyn W ^a   Lin, Min ^a   Banugaria, Suhrad G ^a   Case, Laura E ^a   Li, Jennifer S ^a   O'Grady, Gwendolyn ^a   Heller, James H ^a   Kishnani, Priya S ^a  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acid maltase deficiency; Aspiration; Deglutition; Deglutition disorders; Enzyme replacement therapy; Glycogen storage disease type I; Infantile Pompe disease; Oropharyngeal dysphagia

Indexed keywords

ALPHA GLUCOSIDASE;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; DISEASE SEVERITY; DYSPHAGIA; ENZYME REPLACEMENT; FEMALE; GLYCOGEN STORAGE DISEASE TYPE 2; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; INFANT; MALE; MOTOR PERFORMANCE; PRESCHOOL CHILD; PRIORITY JOURNAL; PULMONARY ASPIRATION; RETROSPECTIVE STUDY; SCHOOL CHILD; SUCKING; SWALLOWING;

ALPHA-GLUCOSIDASES; DEGLUTITION DISORDERS; DISEASE PROGRESSION; ENZYME REPLACEMENT THERAPY; FEMALE; FLUOROSCOPY; GLYCOGEN STORAGE DISEASE TYPE I; GLYCOGEN STORAGE DISEASE TYPE II; HEALTH STATUS INDICATORS; HUMANS; INFANT; MALE; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; STATISTICS AS TOPIC; TIME FACTORS; VIDEO RECORDING;

EID: 79951724461     PISSN: 0179051X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00455-009-9252-x     Document Type: Article

References (27)

1. Hirschhorn R, Reuser AJ. Glycogen storage disease type II: acid alpha-glucosidase (acid maltase deficiency). In: Scriver CR, Beaudet A, Sly WS, Valle D, Childs B, Kinzler KW, et al., editors. The metabolic and molecular bases of inherited disease. New York: McGraw Hill; 2001. p. 3389-420.
2. Kishnani PS, Howell RR. Pompe disease in infants and children. J Pediatr. 2004;144: S35-43. (Pubitemid 38591273)
3. Kishnani PS, Hwu WL, Mandel H, Nicolino M, Yong F, Corzo D. A retrospective, multinational, multicenter study on the natural history of infantile-onset Pompe disease. J Pediatr. 2006;148:671-6.
4. Koeberl DD, Kishnani PS, Chen YT. Glycogen storage disease Types I and II: treatment updates. J Inherit Metab Dis. 2007;30:159-64. (Pubitemid 46487996)
5. Van den Hout HM, Hop W, van Diggelen OP, Smeitink JA, Smit GP, Poll-The BTT, et al. The natural course of infantile Pompe's disease: 20 original cases compared with 133 cases from the literature. Pediatrics. 2003;112:332-40. (Pubitemid 36951395)
6. Kishnani PS, Corzo D, Nicolino M, Byrne B, Mandel H, Hwu WL, et al. Recombinant human acid α-glucosidase: major clinical benefits in infantile-onset Pompe disease. Neurology. 2007;68:99-109. (Pubitemid 46071892)
7. Van den Hout JM, Kamphoven JH, Winkel LP, Arts WF, De Klerk JB, Loonen MC, et al. Long-term intravenous treatment of Pompe disease with recombinant human alpha-glucosidase from milk. Pediatrics. 2004;113:448-57.
8. ® package insert available at http://www.myozyme.com/.
9. Amalfitano A, Bengur AR, Morse RP, Majure JM, Case LE, Veerling DL, et al. Recombinant human acid alpha-glucosidase enzyme therapy for infantile glycogen storage disease type II: results of a phase I/II clinical trial. Genet Med. 2001;3:132-8.
10. Kishnani PS, Nicolino M, Voit T, Rogers RC, Tsai AC, Waterson J, et al. Chinese hamster ovary cell-derived recombinant human acid α-glucosidase in infantile-onset Pompe disease. J Pediatr. 2006;149:89-97. (Pubitemid 44081924)
11. Klinge L, Straub V, Neudorf U, Voit T. Enzyme replacement therapy in classical infantile Pompe disease: results of a 10-month follow-up study. Neuropediatrics. 2005;36:6-11. (Pubitemid 41115324)
12. Klinge L, Straub V, Neudorf U, Schaper J, Bosbach T, Görlinger K, et al. Safety and efficacy of recombinant acid alpha-glucosidase (rhGAA) in patients with classical infantile Pompe disease: results of a phase II clinical trial. Neuromuscul Disord. 2005;15:24-31. (Pubitemid 41556629)
13. Nicolino M, Byrne B, Wraith JE, Leslie N, Mandel H, Freyer DR, et al. Clinical outcomes after long-term treatment with alglucosidase alfa in infants and children with advanced Pompe disease. Genet Med. 2009;11:210-9.
14. Rossi M, Parenti G, Della Casa R, Romano A, Mansi G, Agovino T, et al. Long-term enzyme1 replacement therapy for Pompe disease with recombinant human alpha-glucosidase derived from Chinese hamster ovary cells. J Child Neurol. 2007;22:565-73. (Pubitemid 46951500)
15. Van den DH, Reuser AJ, Vulto AG, Loonen MC, Cromme-Dijkhuis A, Van der Ploeg AT. Recombinant human alpha-glucosidase from rabbit milk in Pompe patients. Lancet. 2000;356:397-8. (Pubitemid 30487498)
16. Van den Hout JMP, Reuser AJJ, Klerk JBC, Arts WF, Smeitink JAM, Van der Ploeg AT. Enzyme therapy for Pompe disease with recombinant human α-glucosidase from rabbit milk. J Inherit Metab Dis. 2001;24:266-74. (Pubitemid 32479420)
17. Case LE, Hanna R, Frush DP, Krishnamurthy V, DeArmey S, Mackey J, et al. Fractures in children with Pompe disease: a potential long-term complication. Pediatr Radiol. 2007;37:437-45. (Pubitemid 46567092)
18. Kamphoven JH, de Ruiter MM, Winkel LP, Van den Hout HM, Bijman J, De Zeeuw CI, et al. Hearing loss in infantile Pompe's disease and determination of underlying pathology in the knockout mouse. Neurobiol Dis. 2004;16:14-20. (Pubitemid 38569791)
19. Ing RJ, Cook DR, Bengur RA, Williams EA, Eck J, Dear Gde L, et al. Anaesthetic management of infants with glycogen storage disease type II: a physiological approach. Paediatr Anaesth. 2004;14:514-9. (Pubitemid 38758675)
20. Wang LY, Ross AK, Li JS, Dearmey SM, Mackey JF, Worden M, et al. Cardiac arrhythmias following anesthesia induction in infantile-onset Pompe disease: a case series. Paediatr Anaesth. 2007;17:738-48. (Pubitemid 47000653)
21. Muller CS, Jones HN, O'Grady G, Suarez AH, Heller JH, Kishnani PS. Language and speech function in children with infantile Pompe disease. J Pediatr Neurol. 2009;7:147-56.
22. Kishnani PS, Steiner RD, Bali D, Berger K, Byrne BJ, Case LE, et al. Pompe disease diagnosis and management guideline. Genet Med. 2006;8:267-88. (Pubitemid 44297314)
23. Piper MC, Darrah J. Motor assessment of the developing infant. Philadelphia: W. B. Saunders; 1994.
24. Russell DJ, Rosenbaum PL, Avery L, Lane M (2002) Gross Motor Function Measure (GMFM-66 and GMFM-88) user's manual. Clinics in Developmental Medicine, No. 159. Mac Keith Press, London
25. Lang RM, Bierig M, Devereaux RB. Recommendations for chamber quantification: a report from the American Society of Echocardiography's guidelines and standards committee and the chamber quantification writing group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005;18:1440-63. (Pubitemid 41821197)
26. Foster BJ, Mackie AS, Mitsnefes M, Ali H, Mamber S, Colan S. A novel method of expressing left ventricular mass relative to body size in children. Circulation. 2008;117:2769-775. (Pubitemid 351770457)
27. Williams S, Witherspoon K, Kavsak P, Patterson C, McBlain J. Pediatric feeding and swallowing problems: an interdisciplinary team approach. Can J Diet Pract Res. 2006;67:185-90. (Pubitemid 46018119)